Literature DB >> 1591078

Consensus on the management of melanoma of the skin in The Netherlands. Dutch Melanoma Working Party.

P Rümke1, J E van Everdingen.   

Abstract

In 1990, the Dutch Melanoma Working Party, in cooperation with the National Organization for Quality Assurance in Hospitals, organised the second consensus conference on the management of melanoma of the skin. The following guidelines were approved: The margin of a therapeutical excision should be 1 cm for melanomas not thicker than 1.0 mm, 2 cm for a thickness of 1.1-2.0 mm, 3 cm for a thickness of 2.1-3.0 mm. No consensus was reached for tumours thicker than 3.0 mm. The conclusion of the histopathological report should state the histological type of melanoma, the thickness, the level of invasion, the presence of ulceration, regression, microsatellitosis and completeness of removal. In melanomas between 1.5 mm and 4 mm, elective lymph node dissection may be considered, but its value has not been proven. Clinically suspicious regional lymph nodes require a therapeutical lymph node dissection, solitary lymph node removal is inappropriate. Prophylactic (adjuvant) regional perfusion in primary melanoma should only be performed in the context of a clinical trial. Regional perfusion is the treatment of choice for satellitosis and/or in-transit metastases of the extremities without evidence of distant metastases. If radiotherapy is indicated, high fractionation doses are required. There is no standard therapy for distant metastases. Routine check radiographs and laboratory studies are unnecessary during the follow-up period. The follow-up period is normally 10 years.

Entities:  

Mesh:

Year:  1992        PMID: 1591078     DOI: 10.1016/s0959-8049(05)80092-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  4 in total

Review 1.  Long-term follow-up for melanoma patients: is there any evidence of a benefit?

Authors:  Natasha M Rueth; Kate D Cromwell; Janice N Cormier
Journal:  Surg Oncol Clin N Am       Date:  2015-01-24       Impact factor: 3.495

Review 2.  Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.

Authors:  Kate D Cromwell; Merrick I Ross; Yan Xing; Jeffrey E Gershenwald; Richard E Royal; Anthony Lucci; Jeffrey E Lee; Janice N Cormier
Journal:  Melanoma Res       Date:  2012-10       Impact factor: 3.599

3.  Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survival.

Authors:  U Hofmann; M Szedlak; W Rittgen; E G Jung; D Schadendorf
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

Review 4.  Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis.

Authors:  Rachel K Voss; Tessa N Woods; Kate D Cromwell; Kelly C Nelson; Janice N Cormier
Journal:  Patient Relat Outcome Meas       Date:  2015-11-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.